Through a partnership with Siemens Healthineers, the CLINITEST® Rapid COVID-19 Antigen Self-Test received FDA EUA for OTC use.

We are is actively monitoring the newly identified SARS-CoV-2 strain.

The FDA worked with a number of agencies in efforts to evaluate the sensitivity and specificity of various COVID-19 serology tests.